Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3
Kayleigh Dodd, Jee Myung Yang, Ming Hong Shen, et al.
Oncogene (2014) Vol. 34, Iss. 17, pp. 2239-2250
Open Access | Times Cited: 297

Showing 1-25 of 297 citing articles:

A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
Yiqun Zhang, Patrick Kwok‐Shing Ng, Melanie H. Kucherlapati, et al.
Cancer Cell (2017) Vol. 31, Iss. 6, pp. 820-832.e3
Open Access | Times Cited: 543
Regulation and metabolic functions of mTORC1 and mTORC2
Angelia Szwed, Eugene Kim, Estela Jacinto
Physiological Reviews (2021) Vol. 101, Iss. 3, pp. 1371-1426
Open Access | Times Cited: 484
mTOR coordinates protein synthesis, mitochondrial activity and proliferation
Masahiro Morita, Simon‐Pierre Gravel, Laura Hulea, et al.
Cell Cycle (2015) Vol. 14, Iss. 4, pp. 473-480
Open Access | Times Cited: 472
Oncogenic Roles of the PI3K/AKT/mTOR Axis
Masahiro Aoki, Teruaki Fujishita
Current topics in microbiology and immunology (2017), pp. 153-189
Closed Access | Times Cited: 340
MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells
Katayoon Pakravan, Sadegh Babashah, Majid Sadeghizadeh, et al.
Cellular Oncology (2017) Vol. 40, Iss. 5, pp. 457-470
Closed Access | Times Cited: 311
The role of STAT3 in leading the crosstalk between human cancers and the immune system
Yu Wang, Yi‐Cheng Shen, Sinan Wang, et al.
Cancer Letters (2017) Vol. 415, pp. 117-128
Open Access | Times Cited: 301
mTOR substrate phosphorylation in growth control
Stefania Battaglioni, Don Benjamin, Matthias Wälchli, et al.
Cell (2022) Vol. 185, Iss. 11, pp. 1814-1836
Open Access | Times Cited: 268
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Zhen Luo, Mingfu Tian, Ge Yang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 250
Translational Control in Cancer
Nathaniel Robichaud, Nahum Sonenberg, Davide Ruggero, et al.
Cold Spring Harbor Perspectives in Biology (2018) Vol. 11, Iss. 7, pp. a032896-a032896
Open Access | Times Cited: 246
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
Brian J. Christmas, Christine I. Rafie, Alexander C. Hopkins, et al.
Cancer Immunology Research (2018) Vol. 6, Iss. 12, pp. 1561-1577
Open Access | Times Cited: 185
mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer
Karen Griselda de la Cruz-López, Mariel Esperanza Toledo Guzmán, Elizabeth Sánchez, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 181
TOR signaling in plants: conservation and innovation
Lin Shi, Yue Wu, Jen Sheen
Development (2018) Vol. 145, Iss. 13
Open Access | Times Cited: 176
Targeting angiogenesis in oncology, ophthalmology and beyond
Yihai Cao, Róbert Langer, Napoleone Ferrara
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 476-495
Open Access | Times Cited: 156
Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management
Cormac McCarthy, Nishant Gupta, Simon R. Johnson, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 11, pp. 1313-1327
Closed Access | Times Cited: 131
The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles
Mohammad‐Javad Sanaei, Sara Razi, Atieh Pourbagheri‐Sigaroodi, et al.
Translational Oncology (2022) Vol. 18, pp. 101364-101364
Open Access | Times Cited: 131
Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts
Joseph W. Guarnieri, Joseph M. Dybas, Hossein Fazelinia, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 708
Closed Access | Times Cited: 112
Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity
Brian Ortmann
BMJ Oncology (2024) Vol. 3, Iss. 1, pp. e000154-e000154
Open Access | Times Cited: 24
The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors
Mohamed S. Dabour, Mina Y. George, Mary R. Daniel, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 159-182
Open Access | Times Cited: 21
HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects
Yi Shi, Daniele M. Gilkes
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access | Times Cited: 5
The molecular code of kidney cancer: A path of discovery for gene mutation and precision therapy
Deqian Xie, Guandu Li, Zhonghua Zheng, et al.
Molecular Aspects of Medicine (2025) Vol. 101, pp. 101335-101335
Open Access | Times Cited: 2
The PI3K/Akt/PTEN/mTOR Pathway: A Fruitful Target for Inducing Cell Death in Rheumatoid Arthritis?
Charles J. Malemud
Future Medicinal Chemistry (2015) Vol. 7, Iss. 9, pp. 1137-1147
Closed Access | Times Cited: 158
Metabolic reprogramming and tolerance during sepsis-induced AKI
Hernando Gómez, John A. Kellum, Claudio Ronco
Nature Reviews Nephrology (2017) Vol. 13, Iss. 3, pp. 143-151
Open Access | Times Cited: 146
mTOR function and therapeutic targeting in breast cancer.
Stephen H Hare, Amanda Harvey
PubMed (2017) Vol. 7, Iss. 3, pp. 383-404
Closed Access | Times Cited: 145
mTORC1 Promotes Metabolic Reprogramming by the Suppression of GSK3-Dependent Foxk1 Phosphorylation
Long He, Ana P. Gomes, Xin Wang, et al.
Molecular Cell (2018) Vol. 70, Iss. 5, pp. 949-960.e4
Open Access | Times Cited: 131
Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma
Jinduan Lin, Shunwang Cao, Yu Wang, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 109
Page 1 - Next Page

Scroll to top